logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Fosun Pharma (02196.HK) repurchased 1.3 million shares for HK$22.24386 million on September 16.

date
16/09/2026
Zhitong Finance APP news, Fosun Pharma (02196.HK) announced that on September 16, 2026, it spent HK$22.24386 million to repurchase 1.3 million shares.
Latest
1 m ago
NATIONAL ELEC H (00213.HK) repurchased 50,000 shares for HK$18,000 on September 16.
3 m ago
Salesforce (CRM.N): A fix is being tested and will be rolled out once verified.
3 m ago
Bilibili-W (09626.HK) granted a total of approximately 4.5808 million restricted share units.
4 m ago
Baidu Group-W (09888.HK) repurchased 565,900 shares for HK$49.9956 million on September 16.
5 m ago
Kexiang Co., Ltd. (300903.SZ) plans to launch a 2026 restricted stock incentive plan.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.